Serial Number | 88866290 |
Word Mark | MANDARA PHARMA |
Filing Date | Thursday, April 9, 2020 |
Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
Status Date | Monday, October 31, 2022 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, August 4, 2020 |
Goods and Services | Pharmaceutical preparations for oral and topical administration to humans for the treatment of glaucoma, fibromyalgia, anxiety, and depression; topically applied transdermal patches for treatment of diseases and disorders in humans, namely, for use in treatment of post-traumatic stress disorder (PTSD), glaucoma, fibromyalgia, anxiety, and depression; dietary feed supplements for cats, dogs, and horses |
Pseudo Mark | MANDARA PHARMACEUTICAL |
Goods and Services | Genetic analysis and testing services in the nature of genetic testing for medical purposes to select pharmaceutical products and treatments based on genetic tests |
Disclaimer with Predetermined Text | "PHARMA" |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Friday, April 17, 2020 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Friday, April 17, 2020 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Mandarapharma, Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 99 - Other |
Address | Toronto, Ontario M5H3S1 CA |
Party Name | Mandarapharma, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | Toronto, Ontario M5H3S1 CA |
Event Date | Event Description |
Monday, October 31, 2022 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
Monday, October 31, 2022 | ABANDONMENT - NO USE STATEMENT FILED |
Wednesday, March 30, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Monday, March 28, 2022 | SOU EXTENSION 3 GRANTED |
Monday, March 28, 2022 | SOU EXTENSION 3 FILED |
Monday, March 28, 2022 | SOU TEAS EXTENSION RECEIVED |
Friday, October 1, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Wednesday, September 29, 2021 | SOU EXTENSION 2 GRANTED |
Wednesday, September 29, 2021 | SOU EXTENSION 2 FILED |
Wednesday, September 29, 2021 | SOU TEAS EXTENSION RECEIVED |
Tuesday, March 30, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Sunday, March 28, 2021 | SOU EXTENSION 1 GRANTED |
Sunday, March 28, 2021 | SOU EXTENSION 1 FILED |
Sunday, March 28, 2021 | SOU TEAS EXTENSION RECEIVED |
Tuesday, September 29, 2020 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, August 4, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, August 4, 2020 | PUBLISHED FOR OPPOSITION |
Wednesday, July 15, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Thursday, July 2, 2020 | ASSIGNED TO LIE |
Monday, June 29, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Monday, June 29, 2020 | EXAMINER'S AMENDMENT ENTERED |
Monday, June 29, 2020 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Monday, June 29, 2020 | EXAMINERS AMENDMENT E-MAILED |
Monday, June 29, 2020 | EXAMINERS AMENDMENT -WRITTEN |
Friday, June 26, 2020 | ASSIGNED TO EXAMINER |
Friday, April 17, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Monday, April 13, 2020 | NEW APPLICATION ENTERED |